Nordic AML Insights: Research and Ph.D. Contributions
This update highlights recent AML research from the Nordic countries, covering topics such as long-term cancer risks following intensive treatment, predictive value of venetoclax sensitivity testing, and new insights into XPO1 as a therapeutic target. The overview also includes data-driven approaches to prognosis and outcomes in real-world settings.
Explore the latest Nordic findings on emerging directions in AML research!
Få tillgång
Om du är läkare, sjuksköterska eller annan vårdpersonal kan du komma åt hela artikeln genom att skapa en profil på BestPractice Nordic.
- Få tillgång
- Om du redan har en profil: Logga in